Corneal Ulcer Treatment Market to Surge from Sales of Broad Spectrum Antibiotics; Set for 1.75X Growth by 2029

Feb 03,2020 | Healthcare, Pharmaceuticals and Medical devices

Increasing contact lens usage, emerging new treatment options such as anti-amoebic drugs, and well-established supply chain operations are expected to fuel the growth of the corneal ulcer treatment market. Various initiatives by global as well as regional organizations, governments, etc., to eliminate avoidable blindness caused due to contact lens use, are helping to increase awareness about corneal ulcer among the general public as well as ophthalmologists. Further, universities and non-profit organizations arranging eye check-up camps further aids in enhancing awareness about corneal ulcers.

FMI - a well-established name in the market research domain - forecasts that, the corneal ulcer treatment market will experience a major upturn in the coming years, reaching a valuation of US$ 1.3 Bn by 2029.

“Low-cost drugs being offered by generic drug manufacturers, especially in emerging countries, has substantially lowered treatment cost, and is giving tough competition to key players in the global corneal ulcer treatment market.”

For More Detailed Insights on Corneal Ulcer Treatment Market

Key Takeaways of Corneal Ulcer Treatment Market Study

  • Treatment of broad-spectrum corneal ulcers using antibiotics is expected to gain traction and contribute more than 75% of revenue share during the forecast period.
  • Growing bacterial keratitis requiring antibiotics for treatment will contribute significantly to the revenue share of the segment.
  • Eye drops or eye ointments dominate the market by form type, as these are relatively cheaper and do not require other interventional and oral route for drug delivery.
  • By distribution channel, retail pharmacies are expected to gain more than 50% of market share during the forecast period.
  • North America is dominating the global corneal ulcer treatment market, while East Asia is expected to offer lucrative growth opportunities, owing to rising healthcare infrastructure and industrialization.
corneal ulcer treatment market share by region

Acquisition - Key Strategy Followed by Leading Manufacturers

Leading manufacturers in the corneal ulcer treatment market are focusing on geographical expansion as well as increased product offerings through partnerships and acquisitions. In order to evaluate cost effective therapy for corneal ulcer treatment, manufacturers are evaluating new drugs via clinical trials For example, in Dec. 2019, Mallinckrodt plc enrolled the first patient in the company’s Phase 4, multi-center, multiple-dose, open-label study to assess the effects of Acthar Gel as a therapy option in patients with severe keratitis.

Want more insights?

A new study by Future Market Insights opines on the evolution of the corneal ulcer treatment market from 2014–2018, and presents demand projections for 2019–2029 on the basis of drug class (antibiotics, antifungals, antivirals, anti-amoebic drugs, corticosteroids, and NSAIDs), indication (bacterial keratitis, fungal keratitis, viral keratitis, and acanthamoeba keratitis), form (tablets, eye drops, and vials), and distribution channel (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), across seven prominent regions.

For additional information, write to the analyst at press@futuremarketinsights.com

About Healthcare division of FMI

The Healthcare team at Future Market Insights has consistently tracked and analyzed rapidly evolving trends and developments in the global healthcare industry, encompassing pharmaceuticals and medical devices markets. The team facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Media Contact

Rahul Pandita

Rahul Pandita

Head – Corporate Communications

Abhishek Budholiya

Abhishek Budholiya

Head – Digital Marketing